Anticancer effects of liriodenine on the cell growth and apoptosis of human breast cancer MCF-7 cells through the upregulation of p53 expression
Authors:
Open Access
- 19 June 2017
- journal article
- Published by Spandidos Publications in Oncology Letters
- Vol. 14 (2) , 1979-1984
Abstract
Liriodenine has wide pharmacological functions in phytochemistry, pharmacology and antitumor activities. The anticancer effects of liriodenine on the cell growth and apoptosis of human breast cancer MCF-7 cells, and the underlying mechanisms, are yet to be elucidated. Therefore, the present study investigated the anticancer effects of liriodenine on the cell growth and apoptosis of human breast cancer MCF-7 cells. We used MTT assay to measure cell growth, and flow cytometer and DAPI staining was used to analyze cell apoptosis. Then, Western blot analysis was executed to measure B-cell lymphoma-2 protein (Bcl-2), cyclin D1, vascular endothelial growth factor (VEGF), and p53 protein expression. The effect of liriodenine induced significant apoptosis and suppression of cell growth of the MCF-7 cells. Furthermore, the potential mechanism underlying its antitumor effect on MCF-7 cells may result from activation of caspase-3 activity, Bcl-2, cyclin D1 and VEGF, and promotion of p53 protein expression in MCF-7 cells. Therefore, the present results indicated that the anticancer effects of liriodenine suppress cell growth and induce the apoptosis of human breast cancer MCF-7 cells through inhibition of Bcl-2, cyclin D1 and VEGF expression, and upregulation of p53 expression. Therefore, liriodenine may be a potential therapy for the treatment of human breast cancer.Keywords
This publication has 28 references indexed in Scilit:
- The Anti-Cancer Activities of Vernonia amygdalina Extract in Human Breast Cancer Cell Lines Are Mediated through Caspase-Dependent and p53-Independent PathwaysPLOS ONE, 2013
- Genistein induces G2/M cell cycle arrest and apoptosis via ATM/p53-dependent pathway in human colon cancer cellsInternational Journal of Oncology, 2013
- p53 suppresses BRCA2-stimulated ATPase and strand exchange functions of human RAD51The Journal of Biochemistry, 2013
- IGFBP-rP1 induces p21 expression through a p53-independent pathway, leading to cellular senescence of MCF-7 breast cancer cellsJournal of Cancer Research and Clinical Oncology, 2012
- Critical Role of p53 Upregulated Modulator of Apoptosis in Benzyl Isothiocyanate-Induced Apoptotic Cell DeathPLOS ONE, 2012
- Liriodenine, Early Antimicrobial Defence in Annona diversifoliaZeitschrift für Naturforschung C, 2011
- Leptin-induced Growth Stimulation of Breast Cancer Cells Involves Recruitment of Histone Acetyltransferases and Mediator Complex to CYCLIN D1 Promoter via Activation of Stat3Journal of Biological Chemistry, 2007
- Liriodenine inhibits the proliferation of human hepatoma cell lines by blocking cell cycle progression and nitric oxide-mediated activation of p53 expressionFood and Chemical Toxicology, 2005
- Anti‐Cancer Effect of Liriodenine on Human Lung Cancer CellsThe Kaohsiung Journal of Medical Sciences, 2004
- Antibacterial and antifungal activity of liriodenine and related oxoaporphine alkaloidsJournal of Pharmaceutical Sciences, 1980